The humanoid robotics race just hit a brutal turning point. If you thought American startups like Tesla or Figure were running away with the industry, look east. Global shipments skyrocketed to 19,100 units in the first half of 2026, marking a 272% jump compared to the previous year.
Shanghai-based AgiBot captured 44% of that global market share, officially overtaking Unitree Robotics for the number one spot. Unitree dropped to second with 31%. Together, these two Chinese companies control roughly three-quarters of the entire planet's humanoid robot shipments.
The Real Numbers Behind the AgiBot Surge
Let's look at what actually happened. AgiBot shipped roughly 8,400 humanoid robots in the first half of 2026. That represents a 562% year-over-year increase. Meanwhile, Unitree pushed out about 5,900 units, growing 170% over the same timeframe.
People love to treat this as a simple horse race between two hardware shops. It isn't. AgiBot's rocket ship growth is tied directly to its aggressive manufacturing scale and a massive wave of capital as the company eyes a major public offering.
Units shipped don't tell the full story, though. Unitree's G1 hero model has crossed 11,000 cumulative units produced, and they still dominate the research, education, and performance-oriented segments. AgiBot, on the other hand, is leaning heavily into industrial and commercial applications.
Why Industrial Adoption Changes Everything
For years, humanoids were expensive lab experiments that could barely walk across a carpet without falling over. That era is dead. Industrial and commercial deployments now account for more than 70% of all humanoid shipments, up from roughly 50% just a year prior.
Factories in China are acting as massive testing grounds. Companies can plug robots straight into assembly lines, logistics hubs, and warehouses.
When you have a domestic manufacturing ecosystem that can source motors, sensors, and batteries locally, your cost per unit drops drastically. That is why Chinese manufacturers captured over 97% of global humanoid shipments in the first half of 2026. Western companies are struggling to match that localized supply chain velocity.
The IPO Rush and Valuation Realities
Both AgiBot and Unitree are chasing massive public market listings to fund their next phase of research and development. AgiBot has been moving toward an initial public offering with reported valuation targets soaring past billions of dollars, backed by heavyweights like Tencent and Hillhouse Investment.
Unitree is also plotting its public debut on the Shanghai STAR Market, targeting a valuation near $7 billion to $9 billion.
Surging revenues look great on a pitch deck, but the underlying business economics are brutal. Intense competition and skyrocketing research expenses mean profit margins are tight. Unitree reported a sharp profit drop in early 2026 as R&D spending ate into margins. Building bipedal hardware that actually survives a grueling ten-hour industrial shift without breaking down is expensive.
Geopolitics and the Road Ahead
Don't ignore the regulatory friction. Overseas markets are getting complicated. U.S. restrictions and new regulatory hurdles, such as recent FCC rules targeting foreign advanced robotics, mean companies like Unitree face roadblocks expanding into Western territories.
If you're building a strategy around hardware procurement or investing in automation stocks, watch the real-world deployment data, not just the shipment press releases. Look at actual operating hours logged in warehouses. Check how many units are performing autonomous tasks without human handlers stepping in every twenty minutes.
AgiBot won the first half of 2026 by scaling production faster than anyone else. The second half belongs to whoever proves their robots can do real work without breaking down.
